Rick E. Winningham - 22 May 2026 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Reporting relationship: Director
Issuer ticker: JAZZ
Reported as of: 22 May 2026
Net transaction value: -$662,143
SEC form: 4
Accepted by SEC: 27 May 2026, 18:13:08 UTC
Prior SEC filing: 22 May 2026
Source filing: View source filing
Reporting owner signature: By: /s/Paz Dizon, as attorney in fact For: Rick E. Winningham

Key filing fact

Rick E. Winningham filed Form 4 for Jazz Pharmaceuticals plc (JAZZ) on 27 May 2026.

Key facts

This page summarizes Rick E. Winningham's Form 4 filing for Jazz Pharmaceuticals plc (JAZZ).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 27 May 2026, 18:13.

Change

Previous filing in this sequence was filed on 22 May 2026.
Current net transaction value: -$662,143.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001302443 Primary reporting owner

Winningham Rick E

Relationship: Director
Address: 5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN 4, IRELAND
Signature: By: /s/Paz Dizon, as attorney in fact For: Rick E. Winningham
Signature date: 27 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

JAZZ transaction

Ordinary Shares

Options Exercise

Transaction value
Shares: +3,415
Change %: +38%
Price: $138.08^*
Shares after: 12,308
Date: 22 May 2026
Ownership: Direct

JAZZ transaction

Ordinary Shares

Sale

Transaction value: $662,143
Shares: -2,741
Change %: -22%
Price: $241.57
Shares after: 9,567
Date: 22 May 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

JAZZ transaction Derivative

Non-Qualified Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -3,415
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 22 May 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 3,415
Exercise price: $138.08
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This non-qualified stock option was granted on August 11, 2016 and vested over a period of one year from September 1, 2016. The options were fully vested as of August 1, 2017.